Deciphera Pharmaceuticals, акция обыкновенная (US24344T1016, DCPH, D05, DCPH.P).
Deciphera (DCPH) Issues Strategic & Corporate Outlook for 2023
Не осуществляет совмещение деятельности с деятельностью по управлению ценными бумагами и другими лицензируемыми видами деятельности. Стоимость инвестиционного пая может как увеличиваться, так и уменьшаться. Результаты инвестирования в прошлом не определяют доходы в будущем. Доходность инвестиций в паевой инвестиционный фонд не гарантируется государством.
DCPH Price is 15. Deciphera Pharmaceuticals stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Our site uses a custom algorithm based on Deep Learning that helps our users to decide if DCPH could be a bad portfolio addition.
К какой отрасли бизнеса относится компания Deciphera Pharmaceuticals Inc? Компания Deciphera Pharmaceuticals Inc относится к сектору экономики Здравоохранение и отрасли Биотехнологии. Какая рыночная стоимость капитализация компании Deciphera Pharmaceuticals Inc? Deciphera Pharmaceuticals, Inc.
Add News to Your Dashboard Take control of your information flow by tailoring your dashboard to include news from the companies that matter most to you. Create a personalized news feed that aligns with your investment strategies so you can stay informed and confidently steer your investment decisions.
Deciphera Pharmaceuticals
dcph news releases related dcph news releases and dcph press releases from the OTCMKTS NASDAQ and NYSE markets. Looking to buy Deciphera Pharmaceuticals Stock? View today's DCPH stock price, trade commission-free, and discuss DCPH stock updates with the investor community. График и курс акций компании Deciphera Pharmaceuticals Inc: котировки, аналитика и прогнозы.
You are here
- Deciphera Pharmaceuticals Inc акции: график, котировки, курс акций DCPH, информация о компании
- Похожие компании
- Deciphera (DCPH) Убыток за четвертый квартал оказался меньше, чем ожидалось, а выручка - выше
- Deciphera Pharmaceuticals DCPH, стоит ли покупать акции компании после обвала?
News for Deciphera Pharmaceuticals Inc Registered Shs
| Loading Chart... | Вчера бумага (DCPH) достигла первой озвученной цели 21 доллар Год и 2 недели = +100% Deciphera Pharmaceuticals-лонг +100% за год. |
| Deciphera Pharmaceuticals News | Markets Insider | Вчера бумага (DCPH) достигла первой озвученной цели 21 доллар Год и 2 недели = +100% Deciphera Pharmaceuticals-лонг +100% за год. |
| DCPH - Deciphera Pharmaceuticals Inc Stock Price and Quote | Customizable Interactive Stock Chart for Deciphera Pharmaceuticals Inc showing Real-time Prices & Technical Studies. Compare Performance vs. Index Returns & more. |
| DCPH - Deciphera Pharmaceuticals Inc News | Morningstar | Стоимость акции Deciphera Pharmaceuticals сегодня, графики динамики котировок, рекомендации. |
| Deciphera Pharmaceuticals News | котировки, информация о дивидендах и история выплат, отчетности компаний за 10 лет, сравнение компаний друг с другом. |
Deciphera (DCPH) Issues Strategic & Corporate Outlook for 2023
Supporting documentation for any claims, if applicable, will be furnished upon request. Tax considerations with options transactions are unique and investors considering options should consult their tax advisor as to how taxes affect the outcome of each options strategy. Options Order Flow Rebate. The exact rebate will depend on the specifics of each transaction and will be previewed for you prior to submitting each trade. This rebate will be deducted from your cost to place the trade and will be reflected on your trade confirmation. Order flow rebates are not available for non-options transactions. For purposes of this section, Bonds exclude treasury securities held in treasury accounts with Jiko Securities, Inc. Investments in Bonds are subject to various risks including risks related to interest rates, credit quality, market valuations, liquidity, prepayments, early redemption, corporate events, tax ramifications and other factors. The value of Bonds fluctuate and any investments sold prior to maturity may result in gain or loss of principal. In general, when interest rates go up, Bond prices typically drop, and vice versa.
Bonds with higher yields or offered by issuers with lower credit ratings generally carry a higher degree of risk. All fixed income securities are subject to price change and availability, and yield is subject to change. Ratings are not recommendations to purchase, hold, or sell securities, and they do not address the market value of securities or their suitability for investment purposes. High-Yield Cash Account. See here for a list of current Partner Banks. Apex Clearing and Public Investing receive administrative fees for operating this program, which reduce the amount of interest paid on swept cash. Neither Public Investing nor any of its affiliates is a bank. Learn more. Alternative Assets.
Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing. Financhill is not an investment advisor and is not registered with the U.
Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U. The content on any of Financhill websites, products or communication is for educational purposes only. Trading stocks, options and other securities involves risk.
Make informed investment decisions based on the latest developments and customize your dashboard with a personalized news feed to stay in the know. Track all pertinent news, from financial results to strategic decisions, as it happens, ensuring you never miss a beat. By knowing the backstory and the current events, you can make investment decisions rooted in comprehensive, real-time insights.
What other companies compete with Deciphera Pharmaceuticals?
Learn More about companies similar to Deciphera Pharmaceuticals. The official website for Deciphera Pharmaceuticals is www. Learn More about contacing Deciphera Pharmaceuticals investor relations. All rights reserved.
Запрос на добавление актива
| DCPH - Акции Deciphera Pharmaceuticals Inc - StockScan | Дивиденды по акции Deciphera Pharmaceuticals (DCPH) в 2024 году. Ближайшие дивиденды неизвестны. Следите за последними новостями и существенными событиями компании. |
| Deciphera Pharmaceuticals Inc (OQ:DCPH) | Компания Deciphera (DCPH) сообщила о лучших, чем ожидалось, результатах четвертого квартала 2023 года, в котором прибыль и выручка превысили соответствующие оце. |
DECIPHERA PHARMACEUTICALS IN (DCPH)
Последние новости по акциям компании Deciphera Pharmaceuticals Inc (DCPH) в Тинькофф Инвестиции. Filter news. Примечательные заявки SEC Deciphera Pharmaceuticals Inc. Котировки акций Deciphera Pharmaceuticals. Финансовые показатели и отчетность МСФО, РСБУ, GAAP. Deciphera Pharmaceuticals график цен акции [NASDAQ:DCPH]. Вчера бумага (DCPH) достигла первой озвученной цели 21 доллар Год и 2 недели = +100% Deciphera Pharmaceuticals-лонг +100% за год. Стоимость акции Deciphera Pharmaceuticals сегодня, графики динамики котировок, рекомендации. Deciphera Pharmaceuticals, Inc. market data, stock Performance, news and recent insider transactions.
Deciphera Pharmaceuticals Inc
Free Report) announced an outlook and planned corporate milestones for 2023. The company outlined certain commercial, clinical and preclinical activities for the year. Последний финансовый отчет, используемый в расчетах, опубликован компанией 7 февраля 2023 г. Динамика цены акции Deciphera Pharmaceuticals, Inc. (DCPH). Free Report) announced an outlook and planned corporate milestones for 2023. The company outlined certain commercial, clinical and preclinical activities for the year. News. Deciphera Pharmaceuticals() Officer Sells US$223.76K in Common Stocks. $Deciphera Pharmaceuticals()$ Officer Martin Daniel C. sold 17,801 shares of Common.
Deciphera Pharmaceuticals, Inc. Stock price
| Deciphera Pharmaceuticals, Inc. | Get today's Deciphera Pharmaceuticals Inc stock market news. Read the latest DCPH headlines, in depth analysis and forecasts. |
| Deciphera Pharmaceuticals LLC (DCPH) История цен на акции: котировки, графики | BeatMarket | The average volume for any stock is also a very valuable indicator of volatility, and DCPH has an average volume of 626.88K. |
| DCPH Seasonal Trends – Financhill | DCPH / Deciphera Pharmaceuticals, Inc. |
| Deciphera Pharmaceuticals (DCPH) Stock News & Sentiment | 09.02.24 • Новости компаний • Корпоративные новости и динамика нефти улучшили настрой российского рынка Рынок ушел на. |
Оценка новостей
- Deciphera Pharmaceuticals LLC (DCPH) Stock Forecast, Price Targets and Analysts Predictions
- DCPH Stock Quote Price and Forecast | CNN
- od: инвестиции и трейдинг – Telegram
- Deciphera Pharmaceuticals News
- Deciphera (DCPH) Issues Strategic & Corporate Outlook for 2023